Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2025-2033

Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A1488

​1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Glioblastoma Multiforme Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Drug Type
    5.5    Market Breakup by Route of Administration
    5.6    Market Breakup by Type of Molecule
    5.7    Market Breakup by Distribution Channel
    5.8    Market Breakup by Region
    5.9    Market Forecast
6   Market Breakup by Drug Type
    6.1    Temozolomide
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Bevacizumab
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Carmustine
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Radiosensitizers
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Parenteral
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Type of Molecule
    8.1    Small Molecule
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Biologics
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Europe
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Asia Pacific
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Middle East and Africa
        10.4.1 Market Trends
        10.4.2 Market Forecast
    10.5    Latin America
        10.5.1 Market Trends
        10.5.2 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Sun Pharmaceutical Industries 
        15.3.2    Celldex Therapeutics 
        15.3.3    Pfizer 
        15.3.4    F. Hoffmann La Roche 
        15.3.5    Bristol-Myers Squibb 
        15.3.6    Teva Pharmaceuticals 
        15.3.7    Exelixis 
        15.3.8    Angiochem 
        15.3.9    Arbor Pharmaceuticals 

List of Figures

Figure 1: Global: Glioblastoma Multiforme Treatment Market: Major Drivers and Challenges
Figure 2: Global: Glioblastoma Multiforme Treatment Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Glioblastoma Multiforme Treatment Market: Breakup by Drug Type (in %), 2024
Figure 4: Global: Glioblastoma Multiforme Treatment Market: Breakup by Route of Administration (in %), 2024
Figure 5: Global: Glioblastoma Multiforme Treatment Market: Breakup by Type of Molecule (in %), 2024
Figure 6: Global: Glioblastoma Multiforme Treatment Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Glioblastoma Multiforme Treatment Market: Breakup by Region (in %), 2024
Figure 8: Global: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Glioblastoma Multiforme Treatment Industry: SWOT Analysis
Figure 10: Global: Glioblastoma Multiforme Treatment Industry: Value Chain Analysis
Figure 11: Global: Glioblastoma Multiforme Treatment Industry: Porter’s Five Forces Analysis
Figure 12: Global: Glioblastoma Multiforme Treatment (Temozolomide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Glioblastoma Multiforme Treatment (Temozolomide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Glioblastoma Multiforme Treatment (Bevacizumab) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Glioblastoma Multiforme Treatment (Bevacizumab) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Glioblastoma Multiforme Treatment (Carmustine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Glioblastoma Multiforme Treatment (Carmustine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Glioblastoma Multiforme Treatment (Radiosensitizers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Glioblastoma Multiforme Treatment (Radiosensitizers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Glioblastoma Multiforme Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Glioblastoma Multiforme Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Glioblastoma Multiforme Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Glioblastoma Multiforme Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Glioblastoma Multiforme Treatment (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Glioblastoma Multiforme Treatment (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Glioblastoma Multiforme Treatment (Small Molecule) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Glioblastoma Multiforme Treatment (Small Molecule) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Glioblastoma Multiforme Treatment (Biologics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Glioblastoma Multiforme Treatment (Biologics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Glioblastoma Multiforme Treatment Market: Sales through Hospitals (in Million USD), 2019 & 2024
Figure 31: Global: Glioblastoma Multiforme Treatment Market Forecast: Sales through Hospitals (in Million USD), 2025-2033
Figure 32: Global: Glioblastoma Multiforme Treatment Market: Sales through Pharmacies (in Million USD), 2019 & 2024
Figure 33: Global: Glioblastoma Multiforme Treatment Market Forecast: Sales through Pharmacies (in Million USD), 2025-2033
Figure 34: Global: Glioblastoma Multiforme Treatment Market: Sales through Other Distribution Channels (in Million USD), 2019 & 2024
Figure 35: Global: Glioblastoma Multiforme Treatment Market Forecast: Sales through Other Distribution Channels (in Million USD), 2025-2033
Figure 36: North America: Glioblastoma Multiforme Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: North America: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Europe: Glioblastoma Multiforme Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Europe: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Asia Pacific: Glioblastoma Multiforme Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Asia Pacific: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Middle East and Africa: Glioblastoma Multiforme Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Middle East and Africa: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Latin America: Glioblastoma Multiforme Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Latin America: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

Table 1: Global: Glioblastoma Multiforme Treatment Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 3: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Type of Molecule (in Million USD), 2025-2033
Table 5: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Glioblastoma Multiforme Treatment Market: Competitive Structure
Table 8: Global: Glioblastoma Multiforme Treatment Market: Key Players

Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials